{"id":2050602,"date":"2023-09-30T09:21:02","date_gmt":"2023-09-30T13:21:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/class-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices\/"},"modified":"2023-09-30T09:22:48","modified_gmt":"2023-09-30T13:22:48","slug":"class-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/class-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices\/","title":{"rendered":"Remdesivir manufacturer faces class-action lawsuit for alleged deception."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">16<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fclass-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2050602&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><blockquote>\n<h2>The Dark Side of Remdesivir: \u200cLawsuit Alleges Deceptive Promotion \u2064and Hidden Side Effects<\/h2>\n<p>The company \u200dbehind the widely-used \u2063COVID-19 treatment, remdesivir, is\u200d facing \u2062a class-action lawsuit for allegedly misleadingly promoting the drug without \u2063disclosing\u200c its <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/vaccine-maker-biontech-looking-into-reports-of-heart-inflammation\/\" title=\"Vaccine maker BioNTech looking into reports of heart inflammation\">potential side effects<\/a>.<\/p>\n<div class=\"my-5\">In a shocking turn of events, two California residents, including a relative of a remdesivir recipient who \u200btragically passed \u200caway, \u2062have\u200d filed <a href=\"https:\/\/www.documentcloud.org\/documents\/23994749-class-action-complaint-against-gilead-over-remdesivir\" target=\"_blank\" rel=\"noopener\">a lawsuit<\/a> against\u2064 Gilead Sciences. The lawsuit was\u200d filed \u2062in Shasta County on September 26.<\/div>\n<p>The plaintiffs, Deborah\u2063 Fust and\u2062 Edward Pimentel, accuse Gilead of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/class-action-lawsuit-filed-against-remdesivir-manufacturer-over-alleged-deceptive-practices\/\" title=\"Remdesivir manufacturer faces class-action lawsuit for alleged deception.\">deliberately concealing documented side effects<\/a> of remdesivir in their promotional materials. Deborah Fust, who lost her spouse \u2063Michael Fust, and Edward \u2063Pimentel,\u2063 who suffered injuries \u2064after receiving the drug,\u2062 claim \u2063that Gilead\u200b failed to warn them about the potential \u200bdangers.<\/p>\n<div class=\"shortcode\">\n    <!--$--><\/p>\n<div class=\"border-comp-divider mb-4 mr-4 w-full max-w-[500px] border px-5 py-4 text-[16px] leading-[20px] text-[#262626] md:float-left\" id=\"in_article_related_stories\">\n<h2 class=\"mb-3 font-sans text-[16px] font-semibold uppercase leading-[19px] text-[#2F2F2F]\">Related\u2063 Stories<\/h2>\n<div class=\"mb-4 flex gap-2\">\n<div class=\"grow\">\n<div class=\"mb-1 line-clamp-2\">\n            <a href=\"http:\/\/www.theepochtimes.com\/health\/groundbreaking-ruling-manufacturer-of-remdesivir-not-shielded-by-prep-act-for-mans-injuries-5456783?ea_src=author_manual&#038;ea_med=related_stories\"><\/p>\n<h3>Groundbreaking Ruling: Manufacturer of Remdesivir Not Shielded by PREP Act \u200cfor Man\u2019s Injuries<\/h3>\n<p>            <\/a>\n          <\/div>\n<div class=\"text-comp-caption text-[14px] leading-[18px]\">8\/10\/2023<\/div>\n<\/p><\/div>\n<div class=\"shrink-0 basis-[120px]\">\n          <a href=\"http:\/\/www.theepochtimes.com\/health\/groundbreaking-ruling-manufacturer-of-remdesivir-not-shielded-by-prep-act-for-mans-injuries-5456783?ea_src=author_manual&#038;ea_med=related_stories\"><\/a>\n        <\/div>\n<\/p><\/div>\n<div class=\"mb-4 flex gap-2\">\n<div class=\"grow\">\n<div class=\"mb-1 line-clamp-2\">\n            <a href=\"http:\/\/www.theepochtimes.com\/health\/fda-approves-drug-remdesivir-for-covid-19-treatment-in-people-with-kidney-problems-despite-data-showing-renal-failure-5405788?ea_src=author_manual&#038;ea_med=related_stories\"><\/p>\n<h3>FDA \u2062Approves Drug Remdesivir for COVID-19 \u2062Treatment in People With Kidney Problems, Despite Data Showing Renal Failure<\/h3>\n<p>            <\/a>\n          <\/div>\n<div class=\"text-comp-caption text-[14px] leading-[18px]\">7\/18\/2023<\/div>\n<\/p><\/div>\n<div class=\"shrink-0 basis-[120px]\">\n          <a href=\"http:\/\/www.theepochtimes.com\/health\/fda-approves-drug-remdesivir-for-covid-19-treatment-in-people-with-kidney-problems-despite-data-showing-renal-failure-5405788?ea_src=author_manual&#038;ea_med=related_stories\"><\/a>\n        <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p>    <!--\/$-->\n  <\/div>\n<p>&#8220;This drug \u200dis a ticking time \u200cbomb.\u200d Our nonprofit\u2063 has \u200bgathered hospital records from thousands \u2063of members, revealing a stark contrast in kidney readings \u200dand blood levels before and\u200c after remdesivir treatment,&#8221; stated \u200bBradford Geyer, an attorney\u200b representing the \u2062plaintiffs from the Former Feds Group.<\/p>\n<div class=\"my-5\">The FormerFedsGroup Freedom \u200dFoundation,\u200b a nonprofit organization, has compiled a collection of these cases on <a href=\"https:\/\/formerfedsgroup.org\/cases\/\" target=\"_blank\" rel=\"noopener\">their website<\/a>.<\/div>\n<p>The lawsuit alleges that Gilead intentionally \u2064downplayed or\u2062 omitted crucial information\u2062 about the risks associated with \u2062remdesivir, while emphasizing its supposed benefits and safety.<\/p>\n<div class=\"shortcode post-related-videos\">\n    <!--$--><\/p>\n<div class=\"lazyload-wrapper\">\n<div class=\"lazyload-placeholder\"><\/div>\n<\/p><\/div>\n<p>    <!--\/$-->\n  <\/div>\n<div class=\"my-5\">For \u200cinstance, Gilead&#8217;s official website for \u200dthe drug, also known as \u200dveklury, fails to mention any potential kidney problems. Even the patient handout (<a href=\"https:\/\/www.gilead.com\/-\/media\/files\/pdfs\/medicines\/covid-19\/veklury\/veklury_patient_pi.pdf\" target=\"_blank\" rel=\"noopener\">pdf<\/a>) provided by\u2063 Gilead neglects to\u2062 address these issues.<\/div>\n<p>The lawsuit\u200b states, &#8220;Gilead&#8217;s\u200c advertising claims that remdesivir is a safe and effective treatment for COVID-19 are false and misleading. Gilead knew or should have \u2064known, based on prior studies and data,\u2062 that remdesivir posed a high risk \u2062of <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-tightens-warning-of-heart-issues-after-jj-covid-vaccine\/\" title=\"FDA tightens warning of heart issues after J&#038;J COVID vaccine\">severe adverse effects<\/a> and \u200bdeath.&#8221;<\/p>\n<p>According to the suit, Gilead&#8217;s advertising campaign &#8220;misrepresented \u200band\/or\u2063 omitted crucial information about the drug.&#8221;<\/p>\n<p>Gilead has yet\u200d to respond to requests for comment.<\/p>\n<div class=\"my-5\">The plaintiffs are seeking class status, which would allow two groups of people to join the lawsuit. The first group consists of individuals\u2062 who received remdesivir while hospitalized \u2064with COVID-19 and suffered\u200c serious\u2062 injuries as a\u200d result. The second group includes individuals whose loved ones died after receiving remdesivir during their hospitalization.<\/div>\n<h2>Early \u200bFDA Authorization<\/h2>\n<p>In May 2020,\u2064 the U.S. Food and Drug Administration\u200b (FDA) granted emergency \u2063authorization for remdesivir based \u2064on \u2064a government-sponsored <a href=\"https:\/\/www.theepochtimes.com\/article\/clinical-trial-shows-remdesivir-quickened-recovery-from-covid-19-3332118\" target=\"_blank\" rel=\"noopener\">clinical\u200b trial<\/a>. \u2062However, it was later \u200drevealed that the trial&#8217;s \u200dendpoint was changed\u200b midway, \u200craising concerns about the reliability \u2062of the results.<\/p>\n<div class=\"my-5\">Critics argue that \u2062the change was made to\u200c ensure positive \u200boutcomes. \u200bNotably, a trial conducted\u200c by\u2062 the World Health Organization found that remdesivir did not accelerate recovery time or reduce mortality rates,\u2064 contradicting the U.S. recommendation.<\/div>\n<p>Animal studies and post-approval data have also raised concerns about\u2062 the drug&#8217;s safety \u200cand \u2064effectiveness. Reports from the World \u200bHealth Organization&#8217;s VigiBase database indicate\u2062 a significantly higher incidence \u200cof kidney injuries associated with remdesivir compared to other COVID-19 treatments.<\/p>\n<div class=\"my-5\">Furthermore,\u200b the\u200d FDA requires patients to \u2063disclose\u200d any \u2064pre-existing kidney\u200d problems before receiving remdesivir, as\u200c stated \u2064in \u200btheir official guidelines (<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/214787Orig1s000lbl.pdf\" target=\"_blank\" rel=\"noopener\">pdf<\/a>). Therefore, Gilead&#8217;s failure to disclose the risk of kidney injuries in their \u2064promotional materials is a clear violation of California laws against deceptive practices\u200d and false advertising.<\/div>\n<p>The plaintiffs are seeking \u200bvarious\u200b orders, including\u2062 the establishment of a \u2063class, a halt to \u200dGilead&#8217;s \u2063deceptive \u200cpractices, corrections to previous advertisements, the recall and destruction of misleading materials, restitution, and damages.<\/p>\n<div class=\"my-5\">This lawsuit follows \u2063a recent ruling \u2063in Michigan, where a court determined \u200cthat Gilead could be held liable for a man&#8217;s injuries after receiving contaminated remdesivir. \u2063The court \u2062rejected Gilead&#8217;s claim of immunity under the Public Readiness and Emergency\u2064 Preparedness Act.<\/div>\n<p>As the legal battle\u2062 unfolds, the truth behind Gilead&#8217;s actions and the\u200d extent of \u200bthe FDA&#8217;s involvement will be revealed. The plaintiffs and their lawyers are determined \u200dto \u200duncover the facts and\u2062 hold Gilead\u200d accountable for their alleged negligence.<\/p>\n<\/blockquote>\n<p> <\/p>\n<h2> \u200dWhat \u200dimpact could the outcome\u200d of this\u200b lawsuit have\u200b on the pharmaceutical industry and\u2062 the public&#8217;s trust in\u2064 drug companies<\/h2>\n<p><span>  N text-[14px] leading-[18px]&#8221;>7\/20\/2022<\/div>\n<\/p><\/div>\n<div class=\"shrink-0 basis-[120px]\">\n<p>          <a href=\"http:\/\/www.theepochtimes.com\/health\/fda-approves-drug-remdesivir-for-covid-19-treatment-in-people-with-kidney-problems-despite-data-showing-renal-failure-5405788?ea_src=author_manual&#038;ea_med=related_stories\"><\/a><\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p>    <!--\/--><\/p>\n<\/div>\n<p>Remdesivir, an antiviral drug developed \u2062by Gilead \u2064Sciences, gained widespread attention during the COVID-19 pandemic as a potential treatment option. \u200bIt was \u200dgranted emergency use authorization by the U.S. \u200cFood and\u2062 Drug \u2062Administration (FDA) in May 2020 for the treatment of \u2064COVID-19 patients requiring hospitalization.<\/p>\n<p>However, this recent lawsuit brings to light \u200ballegations \u2063that Gilead\u200d Sciences engaged in deceptive promotion of remdesivir by downplaying \u200cor concealing its potential side effects. \u2063The plaintiffs claim that Gilead failed to adequately warn patients and healthcare professionals about the risks associated with the drug.<\/p>\n<p>Deborah Fust, \u2062one of the plaintiffs, lost her spouse\u2064 Michael \u200cFust, who received remdesivir as \u200dpart of his COVID-19\u2063 treatment and tragically passed away. Edward Pimentel, another\u200b plaintiff,\u200c suffered injuries after\u2062 receiving \u2062the drug. \u200cBoth\u200c plaintiffs allege that \u2063they were not \u2062properly informed of the potential\u200d side \u200beffects, \u2064which may have \u200cinfluenced their decisions\u200c regarding \u200cthe treatment.<\/p>\n<p>The lawsuit accuses Gilead Sciences of negligence, fraud, strict liability, and violation of consumer\u2062 protection laws. It alleges that \u2062Gilead intentionally concealed and misrepresented the risks\u2063 of\u2063 remdesivir in \u2062order to boost sales and profits.<\/p>\n<p>This lawsuit \u200draises important \u2063questions about\u200c the ethics of \u2063pharmaceutical companies and their responsibility in providing \u200baccurate and transparent information about\u2062 the risks\u2062 and benefits of their drugs. Patients and healthcare professionals rely on this\u200b information to\u200d make informed decisions about treatment options.<\/p>\n<p>While remdesivir has shown promise in some clinical trials for shortening the recovery time of hospitalized COVID-19 patients,\u200d it \u200bis crucial that the potential side effects\u200b and risks associated with its use are made known to\u2063 patients and\u200c healthcare professionals.<\/p>\n<p>The \u2064outcome of this lawsuit will not only \u2064affect Gilead Sciences \u2062but also \u200bhave broader implications for \u200cthe pharmaceutical industry as a whole. It highlights the \u2064importance of transparency\u200c and accountability in drug promotion and underscores the need for rigorous evaluation of the safety \u2063and efficacy of treatments.<\/p>\n<p>As the COVID-19 pandemic continues to evolve, it is essential that patients \u2064and healthcare professionals have \u2063access \u2062to accurate and reliable \u2063information\u2063 about \u2062the potential risks and benefits of treatments. \u200bThe allegations made in \u2064this lawsuit serve as a reminder that the dark\u200d side of pharmaceuticals can have\u2062 serious consequences and that the \u2062public&#8217;s trust \u2063in the \u200dindustry hinges on the ethical practices \u200dof companies.<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"<p>A class-action lawsuit has been filed against Gilead Sciences, the manufacturer of remdesivir, a widely used COVID-19 treatment in the US. The lawsuit alleges that the company deceptively promoted the drug without disclosing its potential side effects. Two California residents, including a relative of a remdesivir recipient who passed away, initiated the legal action.<\/p>\n","protected":false},"author":75,"featured_media":2050603,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[543],"tags":[],"class_list":["post-2050602","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-the-epoch-times"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2050602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/75"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2050602"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2050602\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2050603"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2050602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2050602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2050602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}